REQUEST A DEMO
Total
USD $0.00
Search more companies

Suiphar International Sa (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Suiphar International Sa Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

The company Suiphar International Sa is primarily engaged in scientific research and development services and related activities. It's been operating in the Colombian market since 1987.

Headquarters
Calle 97 A No 8 - 10 Ofc 303
Bogota D.C.; Bogota D.C; Postal Code: 0810

Contact Details: Purchase the Suiphar International Sa report to view the information.

Basic Information
Total Employees:
Purchase the Suiphar International Sa report to view the information.
Outstanding Shares:
Purchase the Suiphar International Sa report to view the information.
Registered Capital:
Purchase the Suiphar International Sa report to view the information.
Incorporation Date:
March 03, 1987
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
Subsidiaries
Biolatam S A S
Colompack S A
Suiphar de Colombia S.A.S
Company Performance
Financial values in the chart are available after Suiphar International Sa report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
57.39%
Total operating revenue
56.96%
Operating profit (EBIT)
4.09%
EBITDA
4.36%
Net Profit (Loss) for the Period
-16.18%
Total assets
12.08%
Total equity
18.41%
Operating Profit Margin (ROS)
-9.19%
Net Profit Margin
-19.05%
Return on Equity (ROE)
-6.41%
Debt to Equity Ratio
-3.66%
Quick Ratio
0.19%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?